HER2/Neu Positive Active Not Recruiting Phase 2 Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01622868Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast CancerTreatment
NCT00684983Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast CancerTreatment
NCT01273610Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast CancerTreatment